• Inati, A., Musallam, K., Wood, J.C., & Taher, A. (2010, April 8). Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease. Blood, 115(14), 2980-1.
• Inati, A., Musallam K. M., Wood, J. C., Sheikh-Taha, M., Daou, L., & Taher, A. T. (2009, December 1). Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. European Journal of Haematology 83(6), 565 - 571.
• Inati, A., Taher, A., Ghorra, S., Koussa, S., Taha, M., Aoun, E., & Sharara, A.I. (2005, August). Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. British Journal of Haematology 130(4), 644 - 646.
• Inati, A., Taher, A., Bou Alawi, W., Koussa, S., Kaspar, H., Shbaklo, H., & Zalloua, P.A. (2003, February). Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. European Journal Haematology, 70(2), 79 - 83.
• Inati, A., Sallan, S.E., Cassady, J.R., Hitchcock-Bryan, S., Clavell, L.A., Belli, J.A., & Sollee, N. (1983, February). Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate. Blood 61(2), 297 - 303.
• Inati, A., Propper, R., & Nathan, D. (1981). Subcutaneous deferoxamine (ScDF) plus hypertransfusion (HiTx) in thalassemia major (TM): A three year follow-up. Pediatric Research 15 (4 II), 817.

• Author of more than 50 publications in peer reviewed scientific journals and of more than 100 abstracts in international meetings.
• Invited speaker at more than 100 international and regional meetings.
• Reviewer of multiple peer reviewed medical journals.

• Founding Faculty, 2009 - present, Medical School, Lebanese American University (Byblos).
• Faculty member, 2009 - present, Hematology Module, Medical School, Lebanese American University (Byblos).
• Faculty member, 2009 - present, European School of Hematology.
• Research associate, 2007 - present, Balamand University.
• Head of the Division of Pediatric Hematology Oncology, 2006 - present, Rafik Hariri University Hospital.
• Medical Director, 2006 - present, Children’s Cancer Center, Rafik Hariri University Hospital.
• Director of Blood Bank, 2001 - present, Nini Hospital.
• Head of the Division of Pediatric Hematology Oncology, 1996 - present, Nini Hospital.
• Consultant Hematologist, 1994 - present, Chronic Care Center.

• Author of more than 50 publications in peer reviewed scientific journals and of more than 100 abstracts in international meetings.
• Invited speaker at more than 100 international and regional meetings.
• Reviewer of multiple peer reviewed medical journals.

• Sickle Cell Disease
• Thalassemia
• Hemostasis
• Pediatric Leukemias
• Preventive Medicine in Pediatrics
• Road safety

• Inati, A., Musallam, K., Wood, J.C., & Taher, A. (2010, April 8). Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease. Blood, 115(14), 2980-1.
• Inati, A., Musallam K. M., Wood, J. C., Sheikh-Taha, M., Daou, L., & Taher, A. T. (2009, December 1). Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. European Journal of Haematology 83(6), 565 - 571.
• Inati, A., Taher, A., Ghorra, S., Koussa, S., Taha, M., Aoun, E., & Sharara, A.I. (2005, August). Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. British Journal of Haematology 130(4), 644 - 646.
• Inati, A., Taher, A., Bou Alawi, W., Koussa, S., Kaspar, H., Shbaklo, H., & Zalloua, P.A. (2003, February). Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. European Journal Haematology, 70(2), 79 - 83.
• Inati, A., Sallan, S.E., Cassady, J.R., Hitchcock-Bryan, S., Clavell, L.A., Belli, J.A., & Sollee, N. (1983, February). Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate. Blood 61(2), 297 - 303.
• Inati, A., Propper, R., & Nathan, D. (1981). Subcutaneous deferoxamine (ScDF) plus hypertransfusion (HiTx) in thalassemia major (TM): A three year follow-up. Pediatric Research 15 (4 II), 817.

• Author of more than fifty publications in scientific journals and over one hundred abstracts in international conferences.
• Invited speaker at more than one hundred international and regional conferences.
• Reviewer for several scientific journals.

education_ar"":""

rn t
• دراسات عليا في أمراض الدم والأورام لدى الأطفال، 1981، المركز الطبّي لمستشفى الأطفال (Children’s Hospital Medical Center ) ومعهد سيدني فاربر للسرطان (Sidney Farber Cancer Institute)، كلية هارفارد الطبية (Harvard Medical School)، الولايات المتحدة الأميركية.rn t
• تدريب في طب الأطفال، 1979، المركز الطبّي لمستشفى الأطفال (Children’s Hospital Medical Center)، كلية هارفارد الطبية (Harvard Medical School)، الولايات المتحدة الأميركية.rn t
• دراسات عليا في طب الأطفال، 1977، جامعة جون هوبكنز، الولايات المتحدة الأميركية.rn t
• دراسات في الطب، 1976، الجامعة الأميركية في بيروت، لبنانrn""

• Founding Faculty, 2009 - present, Medical School, Lebanese American University (Byblos).
• Faculty member, 2009 - present, Hematology Module, Medical School, Lebanese American University (Byblos).
• Faculty member, 2009 - present, European School of Hematology.
• Research associate, 2007 - present, Balamand University.
• Head of the Division of Pediatric Hematology Oncology, 2006 - present, Rafik Hariri University Hospital.
• Medical Director, 2006 - present, Children’s Cancer Center, Rafik Hariri University Hospital.
• Director of Blood Bank, 2001 - present, Nini Hospital.
• Head of the Division of Pediatric Hematology Oncology, 1996 - present, Nini Hospital.
• Consultant Hematologist, 1994 - present, Chronic Care Center.

• Author of more than fifty publications in scientific journals and over one hundred abstracts in international conferences.
• Invited speaker at more than one hundred international and regional conferences.
• Reviewer for several scientific journals.

degrees"":[]}]"

In alignment with her mission to raise awareness and promote preventive and early detection measures for catastrophic blood disorders, she launched a national newborn screening campaign in 2012 to identify inherited hemoglobin disorders. Through this initiative, she determined the exact prevalence of these conditions and enrolled affected children in a comprehensive, free treatment program. Following the death of her son in a car accident in 2006, she established the Georges Nassim Khoriaty Foundation, which provides free medical care to 1,000 children with cancer and blood disorders through its comprehensive Childhood Cancer and Blood Diseases Program, and to 10,000 people through its dispensary. In 2016, seeking to reduce deaths and disabilities caused by road accidents, she founded the GNK Traffic Academy, which educates Lebanese students on safe driving ethics and rules through an ISO-accredited, simulator-based curriculum. Since returning from Harvard University in the 1980s, she has dedicated herself to providing expert medical care and raising health awareness among generations of Lebanese children. Above all, she has mentored junior Lebanese physicians, medical students, residents, and fellows, guiding them to become not only skilled doctors but also compassionate healers.